Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 3911-3912 [2010-1274]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 15 / Monday, January 25, 2010 / Notices
Dated: January 11, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–1158 Filed 1–22–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Board Public Meeting Times and Dates
(All Times Are Pacific Standard Time)
8:45 a.m.–4:30 p.m., February 9, 2010.
9 a.m.–6 p.m., February 10, 2010.
9 a.m.–3 p.m., February 11, 2010.
jlentini on DSKJ8SOYB1PROD with NOTICES
Public Comment Times and Dates (All
Times Are Pacific Standard Time)
4:30 p.m.–6 p.m., February 9, 2010.*
6 p.m.–7:30 p.m., February 10, 2010.*
*Please note that the public comment
periods may end before the times
indicated, following the last call for
comments. Members of the public who
wish to provide public comment should
plan to attend public comment sessions
at the start times listed.
Place: Marriott Manhattan Beach,
1400 Parkview Avenue, Manhattan
Beach, California; Phone: (310) 546–
7511; Fax: (310) 939–1486. Audio
Conference Call via FTS Conferencing.
The USA toll free dial-in number is 1–
866–659–0537 with a pass code of
9933701.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 100
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program (EEOICP) Act of 2000 to advise
the President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
VerDate Nov<24>2008
16:23 Jan 22, 2010
Jkt 220001
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2011.
Purpose: This Advisory Board is
charged with (a) Providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters To Be Discussed: The agenda
for the Advisory Board meeting
includes: NIOSH Program Update and
Program Evaluation Plans; Department
of Labor (DOL) Program Update;
Department of Energy (DOE) Program
Update; OCAS Science Update; Special
Exposure Cohort (SEC) petitions for:
Lawrence Livermore National
Laboratory, Santa Susana Area IV,
Canoga Avenue Facility (Los Angeles
County, California), Lawrence Berkeley
National Laboratory, General Electric
Company (Evendale, Ohio), Blockson
Chemical Company, Chapman Valve
Manufacturing Company, United
Nuclear Corporation (Hematite,
Missouri), Hanger 481 at Kirtland Air
Force Base, Nevada Test Site, and
Westinghouse Electric Corportation
(Bloomfield, New Jersey); SEC Petition
Status Updates; Subcommittee and
Work Group Reports; Board Working
Time; and Conflict of Interest
Requirements.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted in accordance with the
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
3911
redaction policy provided below. Any
written comments received will be
provided at the meeting and should be
submitted to the contact person below
well in advance of the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment), (1) If a
person making a comment gives his or
her name, no attempt will be made to
redact that name. (2) NIOSH will take
reasonable steps to ensure that
individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting
posted on a public Web site. Such
reasonable steps include: (a) A
statement read at the start of each public
comment period stating that transcripts
will be posted and names of speakers
will not be redacted; (b) A printed copy
of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public
comment; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings. (3) If an
individual, in making a statement,
reveals personal information (e.g.,
medical information) about themselves,
that information will not usually be
redacted. The NIOSH FOIA coordinator
will, however, review such revelations
in accordance with the Freedom of
Information Act and the Federal
Advisory Committee Act and if deemed
appropriate, will redact such
information. (4) All disclosures of
information concerning third parties
will be redacted. (5) If it comes to the
attention of the DFO that an individual
wishes to share information with the
Board but objects to doing so in a public
forum, the DFO will work with that
individual, in accordance with the
Federal Advisory Committee Act, to
find a way that the Board can hear such
comments.
Contact Person for More Information:
Theodore Katz, M.P.A., Executive
Secretary, NIOSH, CDC, 1600 Clifton
Road, MS E–20, Atlanta, GA 30333,
Telephone (513) 533–6800, Toll Free
1(800) CDC–INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
E:\FR\FM\25JAN1.SGM
25JAN1
3912
Federal Register / Vol. 75, No. 15 / Monday, January 25, 2010 / Notices
Dated: January 14, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Dated: January 15, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC) .
DEPARTMENT OF HOMELAND
SECURITY
[FR Doc. 2010–1274 Filed 1–22–10; 8:45 am]
[FR Doc. 2010–1275 Filed 1–22–10; 8:45 am]
[Docket ID: FEMA–2009–0001]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Institutes of Health
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
jlentini on DSKJ8SOYB1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Times and Dates: 9 a.m.–5 p.m., February
11, 2010. 9 a.m.–12 p.m., February 12, 2010.
Place: CDC, Global Communications
Center, Building 19, Auditorium B3, 1600
Clifton Road, NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The Committee is charged with
providing advice and guidance to the
Secretary; the Assistant Secretary for Health;
the Director, CDC; and the Director, National
Center for Preparedness, Detection, and
Control of Infectious Diseases (NCPDCID),
regarding: (1) The practice of hospital
infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters To Be Discussed: The agenda will
include updates on CDC healthcareassociated infections Recovery Act efforts;
discussion on the draft guideline for
prevention of intravascular catheter-related
bloodstream infections; and the draft
guideline for the prevention and management
of norovirus gastroenteritis outbreaks in
healthcare settings.
Agenda items are subject to change as
priorities dictate.
For Further Information Contact: Michelle
W. King, Committee Management Specialist,
Division of Healthcare Quality Promotion,
NCPDCID, CDC, 1600 Clifton Road, NE.,
Mailstop A–07, Atlanta, Georgia 30333,
Telephone (404) 639–2936.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
VerDate Nov<24>2008
16:23 Jan 22, 2010
Jkt 220001
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Molecular
Mechanisms of Neurodegeneration.
Date: January 27, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Lawrence Baizer, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152,
MSC 7850, Bethesda, MD 20892, (301) 435–
1257, baizerl@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 15, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–1225 Filed 1–22–10; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
Federal Emergency Management
Agency
Agency Information Collection
Activities: Proposed Collection;
Comment Request, 1660–0076; Hazard
Mitigation Grant Program Application
and Reporting
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice; 60-day notice and
request for comments; revision of a
currently approved information
collection; OMB No. 1660–0076; No
Form.
SUMMARY: The Federal Emergency
Management Agency, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on a proposed revision of a
currently approved information
collection. In accordance with the
Paperwork Reduction Act of 1995, this
Notice seeks comments concerning the
Hazard Mitigation Grant Program
application and reporting requirements.
DATES: Comments must be submitted on
or before March 26, 2010.
ADDRESSES: To avoid duplicate
submissions to the docket, please use
only one of the following means to
submit comments:
(1) Online. Submit comments at
https://www.regulations.gov under
docket ID FEMA–2009–0001. Follow the
instructions for submitting comments.
(2) Mail. Submit written comments to
Office of Chief Counsel, Regulation and
Policy Team, DHS/FEMA, 500 C Street,
SW., Room 835, Washington, DC 20472–
3100.
(3) Facsimile. Submit comments to
(703) 483–2999.
(4) E-mail. Submit comments to
FEMA-POLICY@dhs.gov. Include docket
ID FEMA–2009–0001 in the subject line.
All submissions received must
include the agency name and docket ID.
Regardless of the method used for
submitting comments or material, all
submissions will be posted, without
change, to the Federal eRulemaking
Portal at https://www.regulations.gov,
and will include any personal
information you provide. Therefore,
submitting this information makes it
public. You may wish to read the
Privacy Act notice that is available on
the Privacy and Use Notice link on the
Administration Navigation Bar of https://
www.regulations.gov.
E:\FR\FM\25JAN1.SGM
25JAN1
]]>Agencies
[Federal Register Volume 75, Number 15 (Monday, January 25, 2010)]
[Notices]
[Pages 3911-3912]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-1274]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Board Public Meeting Times and Dates (All Times Are Pacific Standard
Time)
8:45 a.m.-4:30 p.m., February 9, 2010.
9 a.m.-6 p.m., February 10, 2010.
9 a.m.-3 p.m., February 11, 2010.
Public Comment Times and Dates (All Times Are Pacific Standard Time)
4:30 p.m.-6 p.m., February 9, 2010.*
6 p.m.-7:30 p.m., February 10, 2010.*
*Please note that the public comment periods may end before the
times indicated, following the last call for comments. Members of the
public who wish to provide public comment should plan to attend public
comment sessions at the start times listed.
Place: Marriott Manhattan Beach, 1400 Parkview Avenue, Manhattan
Beach, California; Phone: (310) 546-7511; Fax: (310) 939-1486. Audio
Conference Call via FTS Conferencing. The USA toll free dial-in number
is 1-866-659-0537 with a pass code of 9933701.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health and
Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final rule,
advice on the scientific validity and quality of dose estimation and
reconstruction efforts being performed for purposes of the compensation
program, and advice on petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2011.
Purpose: This Advisory Board is charged with (a) Providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters To Be Discussed: The agenda for the Advisory Board meeting
includes: NIOSH Program Update and Program Evaluation Plans; Department
of Labor (DOL) Program Update; Department of Energy (DOE) Program
Update; OCAS Science Update; Special Exposure Cohort (SEC) petitions
for: Lawrence Livermore National Laboratory, Santa Susana Area IV,
Canoga Avenue Facility (Los Angeles County, California), Lawrence
Berkeley National Laboratory, General Electric Company (Evendale,
Ohio), Blockson Chemical Company, Chapman Valve Manufacturing Company,
United Nuclear Corporation (Hematite, Missouri), Hanger 481 at Kirtland
Air Force Base, Nevada Test Site, and Westinghouse Electric
Corportation (Bloomfield, New Jersey); SEC Petition Status Updates;
Subcommittee and Work Group Reports; Board Working Time; and Conflict
of Interest Requirements.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted in accordance with the redaction policy provided below. Any
written comments received will be provided at the meeting and should be
submitted to the contact person below well in advance of the meeting.
Policy on Redaction of Board Meeting Transcripts (Public Comment),
(1) If a person making a comment gives his or her name, no attempt will
be made to redact that name. (2) NIOSH will take reasonable steps to
ensure that individuals making public comment are aware of the fact
that their comments (including their name, if provided) will appear in
a transcript of the meeting posted on a public Web site. Such
reasonable steps include: (a) A statement read at the start of each
public comment period stating that transcripts will be posted and names
of speakers will not be redacted; (b) A printed copy of the statement
mentioned in (a) above will be displayed on the table where individuals
sign up to make public comment; (c) A statement such as outlined in (a)
above will also appear with the agenda for a Board Meeting when it is
posted on the NIOSH Web site; (d) A statement such as in (a) above will
appear in the Federal Register Notice that announces Board and
Subcommittee meetings. (3) If an individual, in making a statement,
reveals personal information (e.g., medical information) about
themselves, that information will not usually be redacted. The NIOSH
FOIA coordinator will, however, review such revelations in accordance
with the Freedom of Information Act and the Federal Advisory Committee
Act and if deemed appropriate, will redact such information. (4) All
disclosures of information concerning third parties will be redacted.
(5) If it comes to the attention of the DFO that an individual wishes
to share information with the Board but objects to doing so in a public
forum, the DFO will work with that individual, in accordance with the
Federal Advisory Committee Act, to find a way that the Board can hear
such comments.
Contact Person for More Information: Theodore Katz, M.P.A.,
Executive Secretary, NIOSH, CDC, 1600 Clifton Road, MS E-20, Atlanta,
GA 30333, Telephone (513) 533-6800, Toll Free 1(800) CDC-INFO, E-mail
ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
[[Page 3912]]
Dated: January 14, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-1274 Filed 1-22-10; 8:45 am]
BILLING CODE 4163-18-P
